Tallac Therapeutics Revenue and Competitors

Burlingame,

Location

$83.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tallac Therapeutics's estimated annual revenue is currently $2.5M per year.(i)
  • Tallac Therapeutics's estimated revenue per employee is $77,500
  • Tallac Therapeutics's total funding is $83.2M.

Employee Data

  • Tallac Therapeutics has 32 Employees.(i)
  • Tallac Therapeutics grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Tallac Therapeutics?

Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac's pipeline of immunotherapy candidates are derived from the company's novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a potent Toll-like receptor (TLR9) agonist (T-CpG) for targeted immune activation via systemic administration. Several TRAAC molecules are in various stages of discovery and preclinical development.

keywords:N/A

$83.2M

Total Funding

32

Number of Employees

$2.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Tallac Therapeutics News

2022-04-20 - Form DEF 14A ALX ONCOLOGY HOLDINGS For: Jun 14

Prior to joining us, she was with Tizona Therapeutics, Inc. from July ... We assigned to Tallac Therapeutics our lease with respect to our...

2020-12-01 - Tallac Therapeutics Raises $62M in Series A Financing

Tallac Therapeutics, Inc., a Burlingame, Calif.-based biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer, raised $62m in Series A financing. Backers included venBio Partners, Morningside Venture, Lightstone Ventures, Matrix Partners China, and MRL Ven ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.9M32-29%N/A
#2
$6.5M327%N/A
#3
$3.8M33-3%N/A
#4
$3.8M3327%N/A
#5
$8.7M3314%N/A